Janux Therapeutics Inc (JANX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access JANX Annual Balance Sheets →
A period-by-period view of the balance sheet from Janux Therapeutics Inc to Jun 30 2025 helps clarify how Jun 30 2026's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent27.77
Short-term Investments, Total943.15
Cash & Short-term Investments970.00
Accounts receivable0.15
Notes Receivable, Current6.18
Prepaid Expense And Other Assets Current13.85
Total Current Assets983.34
Equipment/Property/Plant Net11.08
Other Assets, Noncurrent13.24
Restricted Cash Noncurrent0.82
Operating Lease Right Of Use Asset17.87
Total Assets1,007.65
Liabilities
Accounts Payable, Current AC3.02
Accrued Liabilities, Current AC19.51
Other Liabilities, Current37.62
Total Current Liabilities60.15
Total Long-term Debt0.00
Other liabilities, Noncurrent19.52
OperatingLeaseLiabilityNoncurrent19.10
Operating Lease Liability Current2.47
Total Liabilities79.67
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock1,327.94
Retained Earnings / Accumulated Deficit-397.72
Accumulated Other Comprehensive Income-2.31
Other Equity-2.31
Common Stockholder's Equity927.98
Total Stockholder's Equity927.98
Liabilities & Stockholder's Equity1,007.65
4 historic quarters locked

Sign in to unlock the full Janux Therapeutics Inc balance sheet history.

About Janux Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-338078

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.